How are energy investors positioned?
biote Corp. (NASDAQ:BTMD), a company specializing in medicinal chemicals and botanical products with a market capitalization of $174 million and impressive gross profit margins of 71%, announced the resignation of Steven J. Heyer from its board of directors. According to InvestingPro analysis, the company maintains a GREAT financial health score, with strong profitability metrics and positive earnings expectations. The resignation, effective immediately, was disclosed in a recent SEC filing. Heyer’s decision to step down was not due to any disagreement with the company regarding its operations, policies, or practices. The board has yet to appoint a successor to fill the vacancy left by Heyer’s departure. This information is based on a press release statement. For deeper insights into biote Corp.’s financial health and growth prospects, including additional ProTips and comprehensive analysis, investors can access the full Pro Research Report available on InvestingPro.
In other recent news, Biote Corp reported its Q1 2025 earnings, delivering results that exceeded Wall Street expectations. The company achieved an earnings per share (EPS) of $0.37, significantly surpassing the forecasted $0.14, and reported revenue of $49 million, which was higher than the anticipated $47.2 million. This performance was largely driven by a 25.5% increase in dietary supplement sales, contributing to the company’s 4.7% year-over-year revenue growth. Biote Corp also improved its gross profit margin by 300 basis points to 74.3%. The company has announced a restructuring charge expected in Q2 2025. Analyst firms did not provide upgrades or downgrades in the recent reports. The company has provided a revenue guidance range of $202 million to $208 million for the full year 2025, with an expected adjusted EBITDA between $59 million and $64 million. Biote Corp plans to implement a strategic organizational restructuring to drive sustainable growth and create long-term value for its shareholders.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.